Toxoplasmosis CT: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Toxoplasmosis}}
{{Toxoplasmosis}}
{{CMG}} ; {{AE}} {{ADG}}
{{CMG}} ; {{AE}} {{ADG}}
Line 29: Line 29:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Infectious disease]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Neurosurgery]]
[[Category:Neurosurgery]]
Line 42: Line 40:
[[Category:Zoonoses]]
[[Category:Zoonoses]]
[[Category:Parasitic diseases]]
[[Category:Parasitic diseases]]
[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Emergency mdicine]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]

Latest revision as of 00:27, 30 July 2020

Toxoplasmosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxoplasmosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxoplasmosis CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxoplasmosis CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxoplasmosis CT

CDC on Toxoplasmosis CT

Toxoplasmosis CT in the news

Blogs on Toxoplasmosis CT

Directions to Hospitals Treating Toxoplasmosis

Risk calculators and risk factors for Toxoplasmosis CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Toxoplasmic encephalitis is the most common cause of intracerebral mass lesions and is thought to be caused by reactivation of chronic infection. Typically cerebral toxoplasmosis manifest as multiple lesions, with a predilection for the basal ganglia, thalami, and corticomedullary junction. Intracerebral mass lesions can be diagnosed using CT scan. Findings of CT brain include multiple hypodense regions predominantly in the basal ganglia and at the corticomedullary junction.

CT

Toxoplasmic encephalitis is the most common cause of intracerebral mass lesions and is thought to be caused by reactivation of chronic infection. Typically cerebral toxoplasmosis manifest as multiple lesions, with a predilection for the basal ganglia, thalami, and corticomedullary junction. Intracerebral mass lesions can be diagnosed using CT scan. Findings of CT brain include:

  • Multiple hypodense regions predominantly in the basal ganglia and at the corticomedullary junction.
  • Size is variable, from less than 1 cm to more than 3 cm, and there may be associated mass effect.
  • Enhancement: following administration of contrast there is nodular or ring enhancement which is typically thin and smooth 5
  • Double-dose delayed scan: may show a central filling on delayed scans
  • Calcification: seen in treated cases; may be dot-like or thick and 'chunky'

Intracranial Toxoplasmosis

References


Template:WikiDoc Sources